Literature DB >> 17141497

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

Felix K H Chun1, Alberto Briganti, Markus Graefen, Andreas Erbersdobler, Jochen Walz, Thorsten Schlomm, Mirja Meschke, Alexander Haese, Luc Valiquette, Hartwig Huland, Pierre I Karakiewicz.   

Abstract

PURPOSE: To test whether body mass index (BMI) improves pre- or post-operative biochemical recurrence (BCR) predictions after radical prostatectomy.
MATERIALS AND METHODS: Pre- and post-operative data were available in 2416 and 2499 men, respectively. Cox regression models addressed the association between BMI and the rate of BCR after adjusting for pre- and post-operative predictors. Predictive accuracy was quantified using Harrell's concordance index, with and without BMI and subjected to 200 bootstraps to reduce overfit bias. Differences in predictive accuracy were compared using the Mantel-Haenszel test.
RESULTS: After adjusting for either pre- or post-operative variables, increasing BMI was a statistically independent risk factor of BCR in both models (both p0.003). Its addition to pre- and post-operative variables respectively increased predictive accuracy measures from 69.6 to 70.2% (+0.6%, p=0.7) and from 78.1 to 78.4% (+0.3%, p=0.8).
CONCLUSION: Our data emphasise that despite its significance, inclusion of BMI into models, to predict BCR, does not improve their accuracy.

Entities:  

Mesh:

Year:  2006        PMID: 17141497     DOI: 10.1016/j.ejca.2006.08.037

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

Review 1.  Energetics in colorectal and prostate cancer.

Authors:  Jeffrey A Meyerhardt; Jing Ma; Kerry S Courneya
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

Review 2.  Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis.

Authors:  Yin Cao; Jing Ma
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-13

3.  Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patients.

Authors:  Jonas Schiffmann; Pierre I Karakiewicz; Michael Rink; L Manka; Georg Salomon; Derya Tilki; Lars Budäus; Raisa Pompe; Sami-Ramzi Leyh-Bannurah; Alexander Haese; P Hammerer; Hartwig Huland; Markus Graefen; Pierre Tennstedt
Journal:  World J Urol       Date:  2018-03-02       Impact factor: 4.226

4.  Low body mass index is associated with adverse oncological outcomes following radical prostatectomy in Korean prostate cancer patients.

Authors:  Kyo Chul Koo; Young Eun Yoon; Koon Ho Rha; Byung Ha Chung; Seung Choul Yang; Sung Joon Hong
Journal:  Int Urol Nephrol       Date:  2014-05-10       Impact factor: 2.370

5.  Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis.

Authors:  Jing Ma; Haojie Li; Ed Giovannucci; Lorelei Mucci; Weiliang Qiu; Paul L Nguyen; J Michael Gaziano; Michael Pollak; Meir J Stampfer
Journal:  Lancet Oncol       Date:  2008-10-03       Impact factor: 41.316

6.  Prostate cancer postoperative nomogram scores and obesity.

Authors:  Jacqueline M Major; Hillary S Klonoff-Cohen; John P Pierce; Donald J Slymen; Sidney L Saltzstein; Caroline A Macera; Dan Mercola; Michael W Kattan
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

7.  Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer.

Authors:  Dieuwertje E G Kok; Joep G H van Roermund; Katja K Aben; Moniek W M van de Luijtgaarden; Herbert F M Karthaus; Oncko B van Vierssen Trip; Ellen Kampman; J Alfred Witjes; Lambertus A L M Kiemeney
Journal:  World J Urol       Date:  2010-12-16       Impact factor: 4.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.